Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about XNAS:ABVC

Recent news which mentions XNAS:ABVC

ABVC BioPharma Announces Potential $7M Cash Licensing Income from Existing Agreements in 2025
Tickers ABVC
Tags XNAS:ABVC ABVC BioPharma, Inc/ en/US
From TheNewswire.com - RSS (Media)
Positive Market Response in Asia Fuels Potential Revenue Growth for ABVC and BioKey, Marching Into Global Dietary Supplements Market of USD 75.35 Billion
Tickers ABVC
Tags XNAS:ABVC ABVC BioPharma, Inc/
From TheNewswire.com - RSS (Media)
ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Tickers ABVC
Tags ABVC BioPharma, Inc/ XNAS:ABVC
From TheNewswire.com - RSS (Media)
ABVC BioPharma s ADHD and MDD Drug Polygala Tenuifolia a Natural Wonder With Potential of Transforming Mental Health Treatment of More Than 30 Billion Market
Tickers ABVC
Tags XNAS:ABVC ABVC BioPharma, Inc/
From TheNewswire.com - RSS (Media)
AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying $150,000 in Licensing Fees
Tickers ABVC
Tags XNAS:ABVC ABVC BioPharma, Inc/
From TheNewswire.com - RSS (Media)
ABVC BioPharma, Inc. Granted Additional 180-Day Grace Period to Regain Compliance With Nasdaq Bid Price Requirement
Tickers ABVC
Tags XNAS:ABVC ABVC BioPharma, Inc/
From TheNewswire.com - RSS (Media)
ABVC BioPharma Secures an Additional Patent for ADHD Treatment, in Addition to the Granted U.S. and Australian Patents, Moving Forward to the Global Patent Map of $32.14 Billion Potential Market
Tickers ABVC
Tags ABVC BioPharma, Inc/ XNAS:ABVC
From TheNewswire.com - RSS (Media)
ABVC BioPharma Receives $296,000 Cash Out of Potential Aggregate License Fee of $24M Cash and Stock From Its Licensees AiBtl, ForSeeCon and OncoX in Global Licensing Deals
Tickers ABVC
Tags ABVC BioPharma, Inc/ XNAS:ABVC
From TheNewswire.com - RSS (Media)
Combination Therapy Holds Promise for Pancreatic Cancer Treatment: A Milestone Collaboration Between ABVC and OncoX, ABVC Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
Tickers ABVC
Tags XNAS:ABVC ABVC BioPharma, Inc/
From TheNewswire.com - RSS (Media)
AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
Tickers ABVC
Tags ABVC BioPharma, Inc/ XNAS:ABVC
From TheNewswire.com - RSS (Media)
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
Tickers ABVC
Tags ABVC BioPharma, Inc/ XNAS:ABVC
From TheNewswire.com - RSS (Media)
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
Tickers ABVC
Tags XNAS:ABVC ABVC BioPharma, Inc/
From TheNewswire.com - RSS (Media)
AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars
Tickers ABVC
Tags ABVC BioPharma, Inc/ XNAS:ABVC
From TheNewswire.com - RSS (Media)
ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine
Tickers ABVC
Tags ABVC BioPharma, Inc/ XNAS:ABVC
From TheNewswire.com - RSS (Media)
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
Tickers ABVC
Tags XNAS:ABVC ABVC BioPharma, Inc/
From TheNewswire.com - RSS (Media)
ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars
Tickers ABVC
Tags XNAS:ABVC ABVC BioPharma, Inc/
From TheNewswire.com - RSS (Media)
ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)
Tickers ABVC MDD
Tags ABVC BioPharma, Inc/ XNAS:ABVC
From TheNewswire.com - RSS (Media)
ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share
Tickers ABVC
Tags ABVC BioPharma, Inc/ XNAS:ABVC
From TheNewswire.com - RSS (Media)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.